STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

Bio-Techne Stock Price, News & Analysis

TECH NASDAQ

Company Description

Overview

Bio-Techne Corporation (NASDAQ: TECH) is a globally recognized life sciences company offering innovative bioactive reagents, consumables, and instruments. Its extensive portfolio supports a broad spectrum of applications in clinical diagnostics, drug discovery, and biological research. Using advanced immunoassays, spatial biology tools, and protein analysis reagents, Bio-Techne equips scientists with the essential resources to investigate complex biological processes and disease mechanisms.

Core Business Areas

Bio-Techne organizes its operations into two primary segments:

  • Protein Sciences: This segment supplies specialized reagents such as antibodies, cytokines, and growth factors, along with analytical instruments, that serve as critical tools for protein analysis and cell biology. These products are employed in both basic and advanced research settings, reflecting a strong commitment to scientific precision and reproducibility.
  • Diagnostics and Spatial Biology: Focused on clinical diagnostic solutions, this segment offers molecular tests, diagnostic reagents, and spatial biology products. These tools facilitate reliable clinical assays, supporting translational research and precision medicine through enhanced imaging and biomarker analysis.

Global Reach and Market Position

Based in Minnesota, Bio-Techne has established a significant market presence globally. Its products are widely used in North America, Europe, the Middle East, Africa, the UK, and Asia-Pacific. This international footprint, combined with a deep and diverse product catalog, positions the company as a key contributor to high-quality scientific research and diagnostic testing worldwide.

Innovation and Strategic Collaborations

Innovation is at the core of Bio-Techne’s operations. The company invests heavily in research and development to integrate emerging technologies, such as AI-assisted protein design and automated spatial biology platforms, into its product lines. Strategic collaborations with academic institutions, industry partners, and regional distributors further enhance its capabilities and propel breakthrough innovations. These partnerships not only accelerate product development but also ensure that the tools provided are seamlessly integrated into existing research and clinical workflows.

Product Portfolio and Revenue Streams

Bio-Techne offers an extensive inventory of bioactive reagents and research tools. Its products cater to a wide array of scientific needs ranging from basic research to clinical diagnostics. By providing both Research Use Only (RUO) and Good Manufacturing Practice (GMP) grade products, the company meets the rigorous demands of biotechnology, pharmaceutical, and academic sectors. Its revenue is generated through direct sales, licensing agreements, and strategic distribution deals, all of which underscore the company’s role as a pivotal enabler of scientific exploration.

Competitive Landscape

In a crowded marketplace, Bio-Techne stands out by leveraging its robust product portfolio, cutting-edge technological integration, and a proven track record of intellectual property innovation. While competitors offer similar life sciences tools, Bio-Techne differentiates itself with high-quality, reliable products and ongoing legal protections that reinforce its investment in research and development.

Customer Focus and Operational Excellence

The company prioritizes customer success by delivering reproducible and high-performance research tools that enhance scientific discovery. It regularly engages with the scientific community through educational workshops, technical discussions, and industry events, ensuring its customers remain at the forefront of innovation. This commitment to operational excellence has solidified Bio-Techne’s reputation as a trusted partner in both research and clinical diagnostic communities.

Conclusion

Overall, Bio-Techne Corporation is a cornerstone in the life sciences industry. Through its dual focus on Protein Sciences and Diagnostics & Spatial Biology, the company provides essential tools and innovative solutions that empower researchers and clinicians alike. Its global reach, strategic collaborations, and continuous push for technological advancement highlight its pivotal role in advancing biomedical research and clinical diagnostics.

Stock Performance

$59.48
+0.17%
+0.10
Last updated: November 15, 2025 at 16:06
-18.14 %
Performance 1 year

Financial Highlights

$289,458,000
Revenue (TTM)
$33,600,000
Net Income (TTM)
$63,889,000
Operating Cash Flow

Upcoming Events

NOV
18
November 18, 2025 Marketing

Stephens Investment presentation

Presentation at Stephens Investment; webcast via IR calendar
NOV
20
November 20, 2025 Marketing

Jefferies Global Healthcare presentation

Presentation at Jefferies Global Healthcare; webcast via IR calendar
JAN
01
January 1, 2026 - December 31, 2026 Regulatory

GHG targets validation

Validation of science-based GHG reduction targets by SBTi
JAN
01
January 1, 2026 - March 31, 2026 Corporate

Exosome Diagnostics divestiture closing

Expected closing of Exosome Diagnostics sale to Mdxhealth SA
JAN
25
January 25, 2026 Financial

Quarterly interest payment

15% annual interest due on convertible debentures issued Jul 25; payable cash or shares
APR
25
April 25, 2026 Financial

Quarterly interest payment

15% annual interest due on convertible debentures issued Jul 25; payable cash or shares
JUN
01
June 1, 2026 Operations

Düsseldorf customer centre opening

JUL
25
July 25, 2026 Financial

Debenture maturity

12-month maturity of convertible debentures; repay principal or convert to shares at CAD 0.15

Short Interest History

Last 12 Months
Loading short interest data...

Days to Cover History

Last 12 Months
Loading days to cover data...

Frequently Asked Questions

What is the current stock price of Bio-Techne (TECH)?

The current stock price of Bio-Techne (TECH) is $59.38 as of November 14, 2025.

What is the market cap of Bio-Techne (TECH)?

The market cap of Bio-Techne (TECH) is approximately 9.5B. Learn more about what market capitalization means .

What is the revenue (TTM) of Bio-Techne (TECH) stock?

The trailing twelve months (TTM) revenue of Bio-Techne (TECH) is $289,458,000.

What is the net income of Bio-Techne (TECH)?

The trailing twelve months (TTM) net income of Bio-Techne (TECH) is $33,600,000.

What is the earnings per share (EPS) of Bio-Techne (TECH)?

The diluted earnings per share (EPS) of Bio-Techne (TECH) is $0.21 on a trailing twelve months (TTM) basis. Learn more about EPS .

What is the operating cash flow of Bio-Techne (TECH)?

The operating cash flow of Bio-Techne (TECH) is $63,889,000. Learn about cash flow.

What is the profit margin of Bio-Techne (TECH)?

The net profit margin of Bio-Techne (TECH) is 11.61%. Learn about profit margins.

What is the operating margin of Bio-Techne (TECH)?

The operating profit margin of Bio-Techne (TECH) is 13.81%. Learn about operating margins.

What is the gross margin of Bio-Techne (TECH)?

The gross profit margin of Bio-Techne (TECH) is 63.23%. Learn about gross margins.

What is the current ratio of Bio-Techne (TECH)?

The current ratio of Bio-Techne (TECH) is 4.56, indicating the company's ability to pay short-term obligations. Learn about liquidity ratios.

What is the gross profit of Bio-Techne (TECH)?

The gross profit of Bio-Techne (TECH) is $183,017,000 on a trailing twelve months (TTM) basis.

What is the operating income of Bio-Techne (TECH)?

The operating income of Bio-Techne (TECH) is $39,987,000. Learn about operating income.

What are the primary business segments of Bio-Techne Corporation?

The company operates mainly through two segments: Protein Sciences, which provides reagents and analytical instruments, and Diagnostics & Spatial Biology, which focuses on molecular diagnostics and spatial biology products.

How does Bio-Techne support scientific research?

Bio-Techne supplies a broad array of high-quality tools including antibodies, cytokines, and immunoassay kits that enable precise investigations into biological processes and advance drug discovery and clinical diagnostics.

What distinguishes Bio-Techne in a competitive market?

Its differentiation lies in its comprehensive product portfolio, integration of advanced technologies like AI-assisted protein design and automated spatial biology platforms, and strategic global collaborations that enhance product reliability and innovation.

Who are the main customers of Bio-Techne Corporation?

The company’s products serve pharmaceutical companies, biotech firms, academic research institutions, and clinical diagnostic laboratories worldwide.

How does Bio-Techne ensure product quality and reliability?

Through rigorous R&D, adherence to high manufacturing standards (both RUO and GMP), and continual innovation in product design, the company guarantees reproducible and high-performance solutions.

What role do strategic partnerships play for the company?

Strategic collaborations enable Bio-Techne to integrate new technologies, expand its market reach, and foster innovative solutions that enhance both its research and diagnostic product lines.

Can you describe the global presence of Bio-Techne?

Based in Minnesota, Bio-Techne operates globally with significant market penetration in North America, Europe, the Middle East, Africa, the UK, and Asia-Pacific, cementing its role as a major player in the life sciences industry.